SonoStem Technologies, Inc. is an innovative preclinical-stage biotechnology company dedicated to the exploration, advancement, and market introduction of a cutting-edge targeted gene therapeutics platform. With a strong foundation rooted in over three decades of scientific research, our technology harnesses the knowledge gained from extensive studies on various cell and gene therapy methodologies to create an innovative technology platform. We are committed to pushing the boundaries of medical science and developing groundbreaking solutions in the field of gene therapeutics.